Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

10 May 2021: Clinical Research

Type of Necrosis Influences Prognosis in Hepatocellular Carcinoma After the First Transarterial Chemoembolization

Zhi-Juan Wu 1BCDE , Yin-Fa Xie 2B , Xu Chang 2BCD , Lin Zhang 2AE* , Hui-Yong Wu 2B , Ji-Bing Liu 2B , Jian-Xin Zhang 2C , Peng Sun 2C

DOI: 10.12659/MSM.929884

Med Sci Monit 2021; 27:e929884

Table 3 Comparison of the prognosis for the coagulative necrosis and liquefactive necrosis groups.

Coagulative necrosis group (months) (median±SD)Liquefactive necrosis group (months) (median±SD)P value
Overall survival23.27±1.408.83±2.150.004
Progression-free survival9.33±0.963.70±0.440.002
Intrahepatic in situ progression12.23±1.745.53±1.290.008
New intrahepatic metastasis14.33±1.327.20±0.660.009
Extrahepatic progression15.27±3.246.67±1.290.011
SD – standard deviation.

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750